Combatting misconceptions in glaucoma testing

News
Video

Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.

Robert L. Stamper, OD, addressed optometrists about the nuances of glaucoma testing during the recent Glaucoma 3260 meeting.

Video Transcript:

Editor's note: The below transcript has been lightly edited for clarity.

What do you wish more optometrists knew about glaucoma?

Robert L. Stamper, MD: I'd say the variability in presentation, the racial differences in susceptibility to glaucoma, and I would say the fact that glaucoma, by and large, is a slowly progressive disease, and we don't always have to make decisions in the moment, that we can wait and see how it evolves, to see if it's progressing before we initiate or escalatetreatment.

What are the most common misconceptions of glaucoma testing?

Stamper: The most common misconceptions are the infallibility of our diagnostic equipment, which kind of relates back to not having to make a momentary decision, except in extreme, extreme situations. But for the most part, with chronic glaucoma, often our machines aren't programmed to take into account ethnic and racial differences. They're based, often, on a small number of patients to develop a normative database, so what the machine prints out as being "abnormal" may not, in fact, be "abnormal," may just be a product of some genetic difference between 1 person and another. I think one should, again, except in far advanced situations, one has the ability to repeat the examination, make sure that you're where you're comfortable with the results of testing.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
© 2025 MJH Life Sciences

All rights reserved.